Clinical trial

Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral…

NCT00003152 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Terminated

Key facts

NCT number NCT00003152
Title Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
Official title Marrow-Ablative Chemo-Radiotherapy and Autologous Stem Cell Transplantation Followed by Interferon-Alpha Maintenance Treatment Versus Interferon-Alpha Maintenance Treatment Alone After a Chemotherapy-Induced Remission in Patients With Stages III or IV Follicular Non-Hodgkin's Lymphoma. A…
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Collaborators Lymphoma Trials Office Stichting Hemato-Oncologie voor Volwassenen Nederland
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Lymphoma
Intervention type Biological, Drug, Procedure, Radiation
Interventions filgrastim, recombinant interferon alfa, cyclophosphamide, prednisone, vincristine sulfate, autologous bone marrow transplantation, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation, radiation therapy
Enrollment 469
Start date Mar 1, 1997
Primary completion Nov 1, 1999
First posted Aug 2, 2004
Last update posted Jul 2, 2012
Countries Netherlands, United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies